Publications by authors named "Michael W Conner"

Claim this Profile
G
Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species.
Rhiannon N Hardwick, Patrick Brassil, Ilaria Badagnani, Kimberly Perkins, Glenmar P Obedencio, Michael W Conner

Toxicol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paul M. Newberne (1920-2015).
Michael W Conner

Vet Pathol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the toxicologic pathologist in the biopharmaceutical industry.
Susan van Tongeren, Jane A Fagerland, Michael W Conner, Kelly Diegel, Kevin Donnelly

Int J Toxicol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury.
Michael J Segel, Rami Aqeilan, Keren Zilka, Haya Lorberboum-Galski, Shulamit B Wallach-Dayan, Michael W Conner

Int J Exp Pathol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis